NCT00003540View on ClinicalTrials.gov

Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Breast Cancer
Interventions
DRUG

gemcitabine hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003540 - Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel | Biotech Hunter | Biotech Hunter